CA125
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Niraparib Plus Anlotinib for Recurrent Ovarian Cancer (NCT05311579) | Lei Li | 2022-03-27 |
Track CA125 automatically
Every clearance here is in the API, with alerts when new ones post.
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Niraparib Plus Anlotinib for Recurrent Ovarian Cancer (NCT05311579) | Lei Li | 2022-03-27 |
Every clearance here is in the API, with alerts when new ones post.